Judge Jane R Roth's Rulings on Biosimilar Drug Regulation

Explore Judge Jane R Roth's 1 rulings on biosimilar drug regulation. AI-powered summaries and legal analysis.

1

Cases

1

Mixed

Courts

Judge Jane R Roth's Biosimilar Drug Regulation Opinions (1)

Amgen Inc v. Celltrion USA Inc

CA3 Affirms Enbrel Patent Infringement, Reverses Willfulness Finding

Third Circuit · 2025-06-05 · Mixed · Impact: 60/100

Amgen Inc v. Celltrion USA Inc, decided by Third Circuit on June 5, 2025, resulted in a mixed outcome. The Third Circuit affirmed the District Court's finding of infringement of Amgen's patents for it...

Frequently Asked Questions

Q: How many biosimilar drug regulation cases has Judge Jane R Roth decided?

CaseLawBrief tracks 1 biosimilar drug regulation cases decided by Judge Jane R Roth. The count updates as new opinions are published.

Q: What is Judge Jane R Roth's ruling pattern on biosimilar drug regulation cases?

Based on tracked cases, outcomes include: Mixed: 1.

Q: Which courts has Judge Jane R Roth served on for biosimilar drug regulation cases?

Judge Jane R Roth has decided biosimilar drug regulation cases in: ca3.

Explore More

All Judge Jane R Roth Cases All Biosimilar Drug Regulation Cases All Judges All Topics Search